- Vertex Pharmaceuticals | Leadership | Reshma Kewalramani, M. D. , FASN
Reshma Kewalramani, M D , FASN is the Chief Executive Officer and President of Vertex Pharmaceuticals
- Reshma Kewalramani - Wikipedia
Reshma Kewalramani, is the president and chief executive officer of Vertex Pharmaceuticals, a biotechnology company based in Boston, Massachusetts, as of April 1, 2020 [1][2][3] She is the first female CEO of a large US biotech company [2]
- Reshma Kewalramani, MD FASN - CEO and President at Vertex . . . - LinkedIn
CEO and President at Vertex Pharmaceuticals · Experience: Vertex Pharmaceuticals · Education: Harvard Business School · Location: Boston · 500+ connections on LinkedIn View Reshma
- Reshma Kewalramani | CEO and President at Vertex Pharmaceuticals
Reshma Kewalramani is the CEO and President of Vertex Pharmaceuticals A highly experienced medical doctor, clinician, researcher and nephrologist, she is well equipped to lead Vertex to its next stage of growth
- Vertex CEO Reshma Kewalramani gets 4% pay bump to $21. 5M
After another solid year that included 12% growth in the top line, Vertex has bumped up its compensation for CEO Reshma Kewalramani, M D , to $21 5 million, according to the company’s proxy
- Vertex Pharmaceuticals CEO and Key Executive Team - Craft
Vertex Pharmaceuticals's Chief Executive Officer, President Director is Reshma Kewalramani Vertex Pharmaceuticals's key executives include Reshma Kewalramani and 19 others
- Reshma Kewalramani | Fortune
Reshma Kewalramani, who brings her experience as a licensed doctor to her leadership, took the helm as CEO of Vertex Pharmaceuticals in 2020, having previously served as the biopharma company’s
- Dr. Reshma Kewalramani - CNBC
Dr Reshma Kewalramani, Vertex Pharmaceuticals CEO, leads the first biotech to win approval for a therapy using CRISPR gene editing to treat sickle-cell anemia
|